M. Visser

1.7k total citations
38 papers, 1.2k citations indexed

About

M. Visser is a scholar working on Epidemiology, Radiology, Nuclear Medicine and Imaging and Genetics. According to data from OpenAlex, M. Visser has authored 38 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Epidemiology, 11 papers in Radiology, Nuclear Medicine and Imaging and 11 papers in Genetics. Recurrent topics in M. Visser's work include Radiopharmaceutical Chemistry and Applications (11 papers), Neuroendocrine Tumor Research Advances (10 papers) and Estrogen and related hormone effects (8 papers). M. Visser is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (11 papers), Neuroendocrine Tumor Research Advances (10 papers) and Estrogen and related hormone effects (8 papers). M. Visser collaborates with scholars based in Netherlands, United States and Belgium. M. Visser's co-authors include Herjan J.T. Coelingh Bennink, Marion de Jong, Marleen Melis, Eric P. Krenning, Christian F. Holinka, Otto C. Boerman, Jack L. Erion, M. Klebach, Zandrie Hofman and Edgar J. Rolleman and has published in prestigious journals such as International Journal of Cancer, Journal of Neurology Neurosurgery & Psychiatry and Nutrients.

In The Last Decade

M. Visser

34 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Visser Netherlands 24 384 374 305 270 215 38 1.2k
Sharon H. Jackson United States 16 149 0.4× 188 0.5× 137 0.4× 103 0.4× 41 0.2× 25 1.5k
Lisa Godfrey United Kingdom 17 51 0.1× 191 0.5× 178 0.6× 67 0.2× 161 0.7× 41 1.1k
Patrick G. Groothuis Netherlands 33 162 0.4× 314 0.8× 475 1.6× 35 0.1× 103 0.5× 73 2.6k
L. Cervoni Italy 23 99 0.3× 112 0.3× 45 0.1× 232 0.9× 41 0.2× 90 1.4k
Jiangbo Wang United States 18 40 0.1× 266 0.7× 254 0.8× 283 1.0× 71 0.3× 42 1.8k
Hwajeong Lee South Korea 17 154 0.4× 145 0.4× 79 0.3× 88 0.3× 23 0.1× 53 1.2k
D Vandekerckhove Belgium 20 140 0.4× 164 0.4× 98 0.3× 60 0.2× 128 0.6× 70 1000
Xiaoli Hu China 18 148 0.4× 198 0.5× 28 0.1× 136 0.5× 23 0.1× 69 1.0k
Peter Keng United States 22 146 0.4× 403 1.1× 90 0.3× 50 0.2× 44 0.2× 36 1.4k
Paul D. Phillips United States 23 48 0.1× 249 0.7× 148 0.5× 104 0.4× 414 1.9× 49 1.7k

Countries citing papers authored by M. Visser

Since Specialization
Citations

This map shows the geographic impact of M. Visser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Visser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Visser more than expected).

Fields of papers citing papers by M. Visser

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Visser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Visser. The network helps show where M. Visser may publish in the future.

Co-authorship network of co-authors of M. Visser

This figure shows the co-authorship network connecting the top 25 collaborators of M. Visser. A scholar is included among the top collaborators of M. Visser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Visser. M. Visser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Visser, M., Helenius J. Kloosterboer, & Herjan J.T. Coelingh Bennink. (2012). Estetrol prevents and suppresses mammary tumors induced by DMBA in a rat model. Hormone Molecular Biology and Clinical Investigation. 9(1). 95–103. 21 indexed citations
3.
Melis, Marleen, Erik Vegt, Mark Konijnenberg, et al.. (2010). Nephrotoxicity in Mice After Repeated Imaging Using 111In-Labeled Peptides. Journal of Nuclear Medicine. 51(6). 973–977. 26 indexed citations
4.
Melis, Marleen, M. Visser, Stuart Koelewijn, et al.. (2010). Dynamic and Static Small-Animal SPECT in Rats for Monitoring Renal Function After 177Lu-Labeled Tyr3-Octreotate Radionuclide Therapy. Journal of Nuclear Medicine. 51(12). 1962–1968. 29 indexed citations
5.
Melis, Marleen, M. Visser, Mark Konijnenberg, et al.. (2009). Dose-response effect of Gelofusine on renal uptake and retention of radiolabelled octreotate in rats with CA20948 tumours. European Journal of Nuclear Medicine and Molecular Imaging. 36(12). 1968–1976. 40 indexed citations
6.
Visser, M. & Herjan J.T. Coelingh Bennink. (2009). Clinical applications for estetrol. The Journal of Steroid Biochemistry and Molecular Biology. 114(1-2). 85–89. 37 indexed citations
7.
Holinka, Christian F., et al.. (2008). Maternal and fetal estetrol levels during pregnancy. Climacteric. 11(sup1). 69–72. 25 indexed citations
8.
Visser, M., Christian F. Holinka, & Herjan J.T. Coelingh Bennink. (2008). First human exposure to exogenous single-dose oral estetrol in early postmenopausal women. Climacteric. 11(sup1). 31–40. 47 indexed citations
9.
Bennink, Herjan J.T. Coelingh, Anne‐Marie Heegaard, M. Visser, Christian F. Holinka, & Claus Christiansen. (2008). Oral bioavailability and bone-sparing effects of estetrol in an osteoporosis model. Climacteric. 11(sup1). 2–14. 55 indexed citations
10.
Hammond, Geoffrey L., Kevin Hogeveen, M. Visser, & Herjan J.T. Coelingh Bennink. (2008). Estetrol does not bind sex hormone binding globulin or increase its production by human HepG2 cells. Climacteric. 11(sup1). 41–46. 48 indexed citations
11.
Visser, M., Jacqueline Foidart, & Herjan J.T. Coelingh Bennink. (2008). In vitro effects of estetrol on receptor binding, drug targets and human liver cell metabolism. Climacteric. 11(sup1). 64–68. 56 indexed citations
12.
Visser, M., et al.. (2008). Update: Improvement Strategies for Peptide Receptor Scintigraphy and Radionuclide Therapy. Cancer Biotherapy and Radiopharmaceuticals. 23(2). 137–157. 39 indexed citations
13.
Visser, M., et al.. (2007). Estetrol (E4), the forgotten fetal steroid. 14. 2 indexed citations
14.
Melis, Marleen, Eric P. Krenning, Bert F. Bernard, et al.. (2007). Renal uptake and retention of radiolabeled somatostatin, bombesin, neurotensin, minigastrin and CCK analogues: species and gender differences. Nuclear Medicine and Biology. 34(6). 633–641. 54 indexed citations
15.
Rolleman, Edgar J., Eric P. Krenning, Bert F. Bernard, et al.. (2006). Long-term toxicity of [177Lu-DOTA0,Tyr3]octreotate in rats. European Journal of Nuclear Medicine and Molecular Imaging. 34(2). 219–227. 46 indexed citations
16.
Visser, M., A. Srinivasan, Jean Claude Reubi, et al.. (2003). Stabilised 111In-labelled DTPA- and DOTA-conjugated neurotensin analogues for imaging and therapy of exocrine pancreatic cancer. European Journal of Nuclear Medicine and Molecular Imaging. 30(8). 1134–1139. 78 indexed citations
17.
Visser, M., et al.. (2002). Sudden death can not be prevented by pacemaker therapy in patients with lamin A/C mutations. Data Archiving and Networked Services (DANS). 2 indexed citations
18.
Bonne, Gisèle, Rabah Ben Yaou, L. Demay, et al.. (2002). Clinical analysis of 32 patients carrying R453W LMNA mutation. UCL Discovery (University College London). 2 indexed citations
19.
Visser, M., et al.. (1998). Dropped head syndrome and bent spine syndrome: two separate clinical entities or different manifestations of axial myopathy?. Journal of Neurology Neurosurgery & Psychiatry. 65(2). 258–259. 37 indexed citations
20.
Floor, Marianne, et al.. (1994). Effect of Loracarbef and Amoxicillin on the Oropharyngeal and Intestinal Microflora of Patients with Bronchitis. Scandinavian Journal of Infectious Diseases. 26(2). 191–197. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sharon H. Jackson Breakdown of academic impact, for papers by Lisa Godfrey Breakdown of academic impact, for papers by Patrick G. Groothuis Breakdown of academic impact, for papers by L. Cervoni Breakdown of academic impact, for papers by Jiangbo Wang Breakdown of academic impact, for papers by Hwajeong Lee Breakdown of academic impact, for papers by D Vandekerckhove Breakdown of academic impact, for papers by Xiaoli Hu Breakdown of academic impact, for papers by Peter Keng Breakdown of academic impact, for papers by Paul D. Phillips
Rankless by CCL
2026